Authors:
Marttunen, MB
Hietanen, P
Pyrhonen, S
Tiitinen, A
Ylikorkala, O
Citation: Mb. Marttunen et al., A prospective study on women with a history of breast cancer and with or without estrogen replacement therapy, MATURITAS, 39(3), 2001, pp. 217-225
Authors:
Marttunen, MB
Cacciatore, B
Hietanen, P
Pyrhonen, S
Tiitinen, A
Wahlstrom, T
Ylikorkala, O
Citation: Mb. Marttunen et al., Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women, BR J CANC, 84(7), 2001, pp. 897-902
Authors:
Albanes, D
Malila, N
Taylor, PR
Huttunen, JK
Virtamo, J
Edwards, BK
Rautalahti, M
Hartman, AM
Barrett, MJ
Pietinen, P
Hartman, TJ
Sipponen, P
Lewin, K
Teerenhovi, L
Hietanen, P
Tangrea, JA
Virtanen, M
Heinonen, OP
Citation: D. Albanes et al., Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland), CANC CAUSE, 11(3), 2000, pp. 197-205
Authors:
Virtamo, J
Edwards, BK
Virtanen, M
Taylor, PR
Malila, N
Albanes, D
Huttunen, JK
Hartman, AM
Hietanen, P
Maenpaa, H
Koss, L
Nordling, S
Heinonen, OP
Citation: J. Virtamo et al., Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland), CANC CAUSE, 11(10), 2000, pp. 933-939
Authors:
Marttunen, MB
Hietanen, P
Tiitinen, A
Viinikka, L
Ylikorkala, O
Citation: Mb. Marttunen et al., Antiestrogens reduce plasma levels of endothelin-1 without affecting nitrate levels in breast cancer patients, GYNECOL END, 14(1), 2000, pp. 55-59
Authors:
Holli, K
Valavaara, R
Blanco, G
Kataja, V
Hietanen, P
Flander, M
Pukkala, E
Joensuu, H
Citation: K. Holli et al., Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer, J CL ONCOL, 18(20), 2000, pp. 3487-3494
Authors:
Marttunen, MB
Andersson, S
Hietanen, P
Karonen, SL
Koistinen, HA
Koivisto, VA
Tiitinen, A
Ylikorkala, O
Citation: Mb. Marttunen et al., Antiestrogenic tamoxifen and toremifene increase serum leptin levels in postmenopausal breast cancer patients, MATURITAS, 35(2), 2000, pp. 175-179
Authors:
Pyrhonen, S
Salminen, E
Ruutu, M
Lehtonen, T
Nurmi, M
Tammela, T
Juusela, H
Rintala, E
Hietanen, P
Kellokumpu-Lehtinen, PL
Citation: S. Pyrhonen et al., Prospective randomized trial of interferon alfa-2a plus vinblastine versusvinblastine alone in patients with advanced renal cell cancer, J CL ONCOL, 17(9), 1999, pp. 2859-2867
Authors:
Marttunen, MB
Hietanen, P
Titinen, A
Roth, HJ
Viinikka, L
Ylikorkala, O
Citation: Mb. Marttunen et al., Effects of tamoxifen and toremifene on urinary excretion of pyridinoline and deoxypyridinoline and bone density in postmenopausal patients with breast cancer, CALCIF TIS, 65(5), 1999, pp. 365-368
Citation: P. Hietanen et al., Intensified adjuvant cyclophosphamide, methotrexate and 5-fluorouracil therapy: A dose-finding study for ambulatory patients with breast cancer, ONCOL-BASEL, 56(2), 1999, pp. 103-109
Authors:
Joensuu, H
Holli, K
Heikkinen, M
Suonio, E
Aro, AR
Hietanen, P
Huovinen, R
Citation: H. Joensuu et al., Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: A prospective randomized trial, J CL ONCOL, 16(12), 1998, pp. 3720-3730